Company: BIAF
Filing Date: 2025-04-29
Form Type: 10-K/A
Source: 0001641172-25-006707
Chunk: 3

Company: bioAffinity Technologies, Inc.
Filing Date: 2025-04-29
Form: 10-K/A
Chunk 3
---
 filed for the sole purpose of including the information required by Part III of the Annual Report on Form 10-K that was intended to be incorporated by reference to the Company’s definitive proxy statement relating to the 2025 annual meeting of stockholders because such proxy statement will not be filed with the Securities and Exchange Commission within 120 days after the end of the Company’s fiscal year ended December 31, 2024. As required by the SEC, this Amendment includes new certifications pursuant to Sections 302 of the Sarbanes-Oxley Act of 2002, filed as Exhibits 31.3, 31.4, hereto. Because no financial statements are contained within this Amendment, we are not filing currently dated certifications pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. This Amendment has not been updated or amended to give effect to any subsequent events beyond those that existed as of the original filing date and should thus be read in conjunction with the Original Filing and any of the Company’s other filings with the SEC subsequent to the Original Filing, together with any amendments to those filings. Other than the filing of the information identified above, this amendment does not modify or update the disclosure in the Original Filing in any way. Unless otherwise specified or the context otherwise requires, when used in this Amendment, the terms “we,” “our,” “us,” “bioAffinity,” or the “Company” refer to bioAffinity Technologies, Inc. and its subsidiaries.

| 3 |

<div align='center'>PART III</div>

Item 10. Directors, Executive Officers, and Corporate Governance.

The following is a list of the Company’s directors and executive officers as of April 28, 2025.

| Name            |     | Age |     | Position(s)                                    |
| Maria           
 Zannes, JD      |     |  69 |     | President,                                     
 Chief Executive Officer, and Director          |
| James           
 Michael Edwards |     |  58 |     | Chief                                          
 Financial Officer                              |
| Xavier          
 Reveles         |     |  56 |     | Chief                                          
 Operating Officer                              |
| Timothy         
 P. Zannes, JD   |     |  72 |     | Executive                                      
 Vice President, Secretary, and General Counsel |
| Steven          
 Girgenti        |     |  79 |     | Executive                                      
 Chairman and Director                          |
| Robert          
 Anderson        |     |  84 |